Clinical Trial Update: Post-Approval Clinical Trial of the PCM® Cervical Disc [Phase 3]

View source ↗

Summary

Post-approval Phase 3 trial of the PCM Cervical Disc has completed, evaluating outcomes in radiculopathy and myelopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelopathy
• Radiculopathy

Drugs mentioned

• PCM Cervical Disc

Snippet

Sponsor: NuVasive | Conditions: Radiculopathy, Myelopathy | Phase 3 | Status: COMPLETED